There's a second GLP-1 pill now. Foundayo. FDA approved April 1. Shipping from pharmacies as of April 9.
If you've been waiting for a pill instead of a needle, or if your doctor just brought this one up, here's what you need to know before your first dose.
What Is Foundayo and How Is It Different From Wegovy?
Foundayo (orforglipron) is from Eli Lilly, same company behind Zepbound and Mounjaro. Once-daily pill. Targets the GLP-1 receptor, same mechanism as Ozempic, Wegovy, and Mounjaro.
The big difference from the Wegovy pill: this one has no food or water restrictions. Take it any time of day. With or without food, it doesn't matter. The Wegovy pill requires an empty stomach, no more than 4oz water, and a strict 30-minute fast before you eat or drink anything. Foundayo skips all of that.
That's a real win for daily life. You just take a pill and go.
But the side effects? Same family of problems as every other GLP-1.
Foundayo Side Effects: What the Trials Showed
In Eli Lilly's Phase 3 trial, the most common side effects on the highest dose were nausea, constipation, diarrhea, vomiting, indigestion, stomach pain, headache, fatigue, belching, heartburn, gas, and hair loss.
If you've read anything about Ozempic or Wegovy side effects, that list looks identical. Because it basically is.
The no-food-restriction convenience doesn't change what the drug does once it's in your system. It still slows gastric emptying. It still activates your brain's nausea center. Same pathways, easier delivery.
Average weight loss on the highest dose: about 12% of body weight (roughly 27 lbs) over 72 weeks. That's real, but it's less than the injectables. Wegovy injection showed about 15%. Zepbound showed about 21%.
So the trade is: less weight loss ceiling for a pill you can take whenever without thinking about it. For a lot of people that trade makes total sense. But if maximum weight loss matters more than convenience, the injectables still win.
Foundayo vs Wegovy Pill: How Do They Compare?
Two GLP-1 pills on the market now. Here's what matters:
Wegovy pill: 46.6% nausea rate in trials. Must take on empty stomach. 30-minute fasting window. If you break that window, absorption drops and you get inconsistent results. Daily.
Foundayo: Nausea and GI side effects comparable to other GLP-1s. No food or water rules at all. Take any time. Daily.
Why this matters practically: some Wegovy pill users have random bad days that don't make sense. A lot of that is absorption inconsistency from not following the 30-minute rule perfectly. Foundayo removes that variable. The Wegovy pill works great if you're strict about the fasting window. Foundayo is for people who don't want to think about it.
The weight loss gap: Wegovy pill showed 14-17% body weight loss at the highest dose. Foundayo showed about 12%. Wegovy pill wins on weight loss numbers. Foundayo wins on not having to think about it every morning.
The 4 Nausea Drivers Still Apply
Whether you're on Foundayo, the Wegovy pill, or an injectable, nausea from these meds has 4 separate drivers. Most advice only addresses one.
1. Your gut: the drug slows stomach emptying. Food sits longer. Pressure builds. Ginger helps here. Partially.
2. Your brain's nausea center: the drug activates a region called the area postrema directly. This is why you can feel sick on an empty stomach. Ginger doesn't touch this.
3. The anxiety loop: if side effects make you dread taking the pill, that dread creates its own nausea. It gets worse over time. FDA data shows panic attacks at nearly 5x the expected rate on GLP-1 meds.
4. Smooth muscle tension: your GI tract spasms on its own in response to the drug. Feels like nausea but it's a different mechanism.
The "no food restrictions" thing is a real advantage but it only affects Pathway 1. Pathways 2, 3, and 4 don't care whether you ate first. If your nausea is mostly anxiety-driven or brain-driven, switching pills won't fix it.
In clinical settings, nausea is never treated with just one approach. Your protocol should match the pathways that are active for you.
What It Costs and How to Get It
Cash pay: $149/month for the lowest dose. Goes up with higher doses.
Commercial insurance: as low as $25/month with Lilly's savings card.
Medicare Part D: potentially $50/month starting July 1, 2026.
Available now through LillyDirect (ships to your door), retail pharmacies as of April 9, and telehealth providers like Ro. You need a prescription.
Starting Foundayo? Figure Out Your Protocol First.
Easier to take doesn't mean easier on your body. The nausea, constipation, and fatigue hit the same way as every other GLP-1. What you do about it depends on your dose, how long you've been on it, and which of the 4 drivers are most active for you right now.
We built a 30-second quiz that figures out your phase and matches you to a week-by-week protocol. Works for Foundayo, Wegovy pill, Ozempic, Mounjaro, all of them.
Free. More specific than what most prescribers have time to walk you through.
Questions I keep getting about Foundayo:
Is Foundayo better than Ozempic or Wegovy? Different, not better. Foundayo is a daily pill with zero restrictions. Ozempic and Wegovy injection are weekly shots. Wegovy pill is daily with strict rules. The injectables produce more weight loss on average. Foundayo is more convenient. GI side effects are similar across all of them.
Can I switch from Ozempic or Zepbound to Foundayo? Yes, but work with your prescriber on timing. In clinical trials, people switching from injectable Wegovy to Foundayo maintained most of their weight loss with an average regain of only about 2 lbs.
Does Foundayo mess with birth control? Lilly's prescribing info says birth control pills may not work as well while taking Foundayo. Talk to your doctor about backup contraception.
Will Foundayo cause hair loss? It's listed as a common side effect. Like other GLP-1s, this is probably from the rapid weight loss itself, not the drug specifically. Getting enough protein (100g/day minimum) and taking biotin may help.
Take the 30-second GLP-1 side effect quiz. Get a protocol matched to your phase.
Sources: Eli Lilly FDA approval press release, April 1, 2026. ATTAIN-1 Phase 3 trial data. Foundayo prescribing information. GoodRx Foundayo side effects review, April 2026. CNN, April 1, 2026.
Not medical advice. Talk to your prescriber before making changes to your medication or supplement routine.